Results 181 to 190 of about 7,938 (206)

A New Strategy to Identify Naturally Presenting SLA-I Bound Peptides Derived from the O Serotype of Foot-and-Mouth Disease Virus, by Mild Acid Elution in a VP1 Stably Expressed PK15 Cell Line. [PDF]

Animals (Basel)
Gao YY, Zhang ZH, Sang CJ, Han Y, Cao YD, Tang Y, Hu GX, Li ZB, Gao FS.   +8 more
europepmc   +1 more source

Optimizing formaldehyde and binary ethylenimine combinations for inactivation of foot-and-mouth disease virus GR12: insights from Indonesia's third outbreak for local vaccine development. [PDF]

Vet World
Maulana FK, Said NS, Dinana Z, Fahrodi DU, Rahmahani J, Puspitasari Y, Kuncorojakti S, Susilowati H, Diyantoro D, Maryono M, Rantam FA.   +10 more
europepmc   +1 more source

Foot-and-mouth disease virus vaccine with VP1 G-H loop substitution of the Cathay strain broadens antigen spectrum. [PDF]

Appl Microbiol Biotechnol
Zha J, Zhang K, Zhang X, Sun P, Li D, Cao Y, Bai X, Ma X, Li K, Yuan H, Fu Y, Zhang J, Zhao Z, Wang J, Bao H, OuYang Y, Qi S, Liu Z, Lu Z, Li P.   +19 more
europepmc   +1 more source

Tracing the spread and phylogeography of foot-and-mouth disease virus across East and the Horn of Africa. [PDF]

Virus Evol
Makau DN, Arzt J, VanderWaal K.
europepmc   +1 more source

Molecular Interplays of FMDV with the type I IFN Response: Importance of the model & potential links with viral persistence

Sandra Blaise‐Boisseau
openalex   +1 more source

Interactions between the 2C protein of FMDV and components of the viral replication machinery are mediated by ER-derived membranes

Hayward C, Hietanen EV, Dobson SJ, Herod MR, Fontana J, Rowlands DJ, Stonehouse NJ.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pressure-inactivated FMDV: a potential vaccine

Vaccine, 2004
Foot-and-mouth disease virus (FMDV) is the causative agent of the foot-and-mouth disease (FMD). Alternative FMD vaccines have been pursued due to important disadvantages of the one currently in use. High hydrostatic pressure (HP) has been observed to inactivate some viruses.
Daniella, Ishimaru, Daniel, Sá-Carvalho, Jerson L, Silva   +2 more
openaire   +3 more sources

Recombinant T7 Phage with FMDV AKT-III Strain VP1 Protein is a Potential FMDV Vaccine

Biotechnology Letters, 2020
The capsid protein (VP1) of the foot-and-mouth (FMD) AKT-III strain was expressed on the surface of the T7 phage capsid (AKT-T7 strain) and the potential of AKT-T7 strain as an FMD vaccine was evaluated.The AKT-T7 strain was successfully constructed and was not cytotoxic to BHK-21, MDBK, or sheep kidney cells. The AKT-T7 strain was well phagocytosed by
Peng Wu, Xinyue Yin, Qingqing Liu, Wenxing Wu, Chuangfu Chen   +4 more
openaire   +2 more sources

Molecular basis of pathogenesis of FMDV

Virus Research, 2003
Current understanding of the molecular basis of pathogenesis of foot-and-mouth disease (FMD) has been achieved through over 100 years of study into the biology of the etiologic agent, FMDV. Over the last 40 years, classical biochemical and physical analyses of FMDV grown in cell culture have helped to reveal the structure and function of the viral ...
Peter W, Mason, Marvin J, Grubman, Barry, Baxt   +2 more
openaire   +2 more sources

Recombinant pseudorabies virus expressing P12A and 3C of FMDV can partially protect piglets against FMDV challenge

Research in Veterinary Science, 2011
One of the crucial factors for evaluation of an effective genetically engineered vaccine is whether susceptible animals are protected from virus challenge after vaccination. In this study, a recombinant pseudorabies virus (PRV-P12A3C) that expressed capsid precursor polypeptide P12A and nonstructural protein 3C of foot-and-mouth disease virus (FMDV ...
Keshan, Zhang, Jiong, Huang, Qingang, Wang, Yannan, He, Zhuofei, Xu, Min, Xiang, Bin, Wu, Huanchun, Chen   +7 more
openaire   +2 more sources